Your browser doesn't support javascript.
loading
Blood Pressure Changes After a Health Promotion Program Among Mexican Workers.
Garcia-Rojas, Isabel J; Omidakhsh, Negar; Arah, Onyebuchi A; Krause, Niklas.
Afiliação
  • Garcia-Rojas IJ; Fielding School of Public Health, Department of Environmental Health Sciences, University of California, Los Angeles, Los Angeles, CA, United States.
  • Omidakhsh N; Fielding School of Public Health, Department of Environmental Health Sciences, University of California, Los Angeles, Los Angeles, CA, United States.
  • Arah OA; Fielding School of Public Health, Department of Epidemiology, University of California, Los Angeles, Los Angeles, CA, United States.
  • Krause N; Fielding School of Public Health, Department of Epidemiology, University of California, Los Angeles, Los Angeles, CA, United States.
Front Public Health ; 9: 683655, 2021.
Article em En | MEDLINE | ID: mdl-34249846
ABSTRACT

Background:

Cardiovascular disease is becoming increasingly prevalent in low and middle-income countries (LMIC), and high blood pressure (BP) is one of the main risk factors. The efficacy and sustainability of worksite health promotion (WHP) programs for BP reduction in LMIC have yet to be determined.

Methods:

This non-randomized company-based trial evaluated 6- and 12-months effects of a WHP intervention on BP among 2,002 participating workers from seven Mexican companies. Intervention and control groups were assigned at the company level. The intervention included nutrition counseling, physical exercise, and stress management components. Mixed models assessed differences in BP change between intervention and control companies in intent-to-treat (ITT), per-protocol (PerP), and as-treated (AsTr) analyses, and also within-group changes stratified by company, intervention component, and baseline cardiovascular risk factor levels. All analyses were adjusted for potential confounders. We accounted for missing data and loss to follow-up using inverse probability of censoring weighting.

Results:

ITT analyses revealed mean BP change differences of -1.1 mmHg at 12 months (95% CI -2.9; 0.6) in intervention companies relative to control companies. PerP and AsTr analyses confirmed this finding. Within-group analyses showed consistent BP reductions at both 6 and 12 months. Substantial differences in BP changes ranging from diastolic -6.1 mmHg, (95% CI -11.2; -1.2) to systolic -13.0 mmHg (95% CI -16.0; -10.1) were found among individuals with diabetes at baseline in intervention companies relative to control companies.

Conclusion:

After 1 year, WHP was associated with modest but uncertain BP reductions. Substantial reductions were mainly observed among diabetic workers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hipertensão Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Mexico Idioma: En Revista: Front Public Health Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hipertensão Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Mexico Idioma: En Revista: Front Public Health Ano de publicação: 2021 Tipo de documento: Article